UC's $15 million to fight opioid deaths makes local headlines
A recap of media coverage following the HHS' HEALing Communities announcement
On Thursday, April 18, Health and Human Services (HHS) Secretary Alex Azar announced the launch of the HEALing Communities Study to help reverse our nation’s opioid crisis. Four states – Ohio, Kentucky, Massachusetts and New York, will receive over $350 million to support a multi-year study with the goal to cut opioid overdose deaths by 40% in three years. The announcement made news across Ohio and the region.
Funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), University of Cincinnati and Ohio State University will co-lead a $65.9 million effort across Ohio that will also partner with Recovery Ohio and Case Western Reserve University as well as additional universities and community organizations in 19 counties across Ohio. UC will be awarded $15.1 million over four years. Read the full story here.
HEALing Communities Award in the news:
WLW-700 AM(interview at 69:25 minute mark.)
Featured image at top: Jennifer Brown, PhD, presents at the UC / UC Health Opioid Symposium. Photo by Colleen Kelley/AHC Communication Services.
Related Stories
Can new research improve the safety of AI therapy for teens?
December 5, 2025
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition for a discussion on the growing trend of young people turning to artificial intelligence for mental health support and therapy.
Student-designed AI platform aims to match patients to specific cancer support groups
December 5, 2025
The University of Cincinnati is launching a clinical trial testing a student-designed, machine-learning powered platform to match patients with cancer to support groups specifically tailored to their needs and concerns.
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.